Pacific Biosciences of California PACB Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 37.5%+8.9pp | 28.6%+3.2pp | 25.4%+4.0pp | 21.4%+5.2pp | 16.2%-8.0pp | |
| Operating margin | -83.3%+263pp | -346.2%+84.5pp | -430.6%+11.9pp | -442.6%+96.9pp | -539.4%-231pp | |
| Net margin | -80.3%+261pp | -341.5%-14.1pp | -327.3%+11.4pp | -338.7%+94.6pp | -433.3%-231pp | |
| Returns | ||||||
| Return on equity | -273.6%-60.1pp | -213.5%-6.6pp | -206.9%-16.1pp | -190.8%-12.6pp | -178.3%-127pp | |
| Return on invested capital | -304.3%— | —— | -307.3%-19.8pp | -287.5%-50.0pp | -237.4%-146pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.7×+0.5× | 5.1×-1.1× | 6.2×-0.7× | 6.9×+0.2× | 6.7×-0.8× | |
| Leverage | ||||||
| Debt-to-equity | 25.1×+14.4× | 10.7×+9.1× | 1.5×+0.7× | 0.9×+0.3× | 0.6×+0.5× | |
| Per Share | ||||||
| Book value per share | $0.01-56.7% | $0.02-85.2% | $0.12-41.4% | $0.20-33.6% | $0.31-82.4% | |
| Valuation | ||||||
| Market capitalization | $496.96M+30.4% | $564.57M+46.8% | $384.47M+6.8% | $360.1M+2.5% | $351.47M-34.7% | |
| Price / sales | 3.1×+0.6× | 3.5×+1.0× | 2.5×+0.2× | 2.3×0.0× | 2.3×-1.2× | |
| Price / book | 210×+206× | 105.5×+94.9× | 10.7×+4.8× | 5.9×+2.0× | 3.8×+2.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pacific Biosciences of California's profit margins?
- Pacific Biosciences of California (PACB) runs a 37.5% gross margin and a -83.3% operating margin, with a -80.3% net margin.
- Where do Pacific Biosciences of California's ratios come from?
- Every ratio is computed from Pacific Biosciences of California's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
